Duopharma to Expand Portfolio Diversity Including Halal Pharmaceuticals
Highlights: Duopharma has expressed its commitment to expanding its product portfolio diversity by focusing on halal pharmaceuticals and plant-based products. The company aims to increase the availability and affordability of its products to cater to a wider range of consumers. Duopharma is also actively pursuing collaborations to enhance its offerings in preventive medicine and early detection. The company has also secured a three-year contract worth RM375 million to supply Insugen (Insulin Injection) to the Ministry of Health’s facilities.
Link to Original Article
o